SCN’s 2020 research funding competition is now open

In the early in 1960s Canadian researchers Drs. James Till and Ernest McCulloch first proved the existence of stem cells. Their seminal studies launched the international field of stem cell research. Since then Canadian researchers have built upon their work, developing a research enterprise that encompasses not only stem cell biology but also its application in the clinical setting, drug discovery and cell and tissue engineering.

The Stem Cell Network is the national leader for stem cell and regenerative medicine research and has been providing support since 2001. By fostering a research culture and community that embraces a multidisciplinary and collaborative approach, SCN has pushed the boundaries of what was a basic research area towards translational outcomes for patients and emerging businesses. In 2018/19, SCN provided $4M for 24 high-potential research projects: three clinical trials, seven disease teams, and 14 impact projects. SCN has invested $100M in innovative translational research, training and outreach since its inception.

What are stem cells?

Stem cells are our bodies’ building blocks. They are different from other cells because they have the potential to differentiate into any cell type and can renew themselves, which means they can heal blood, tissue and organs.

Read more


In the news

Canada’s Stem Cell Network Investing in Advanced Research on Type 1 Diabetes, Heart Diseases & Vision Loss

Thirteen new projects & clinical trials will engage 200 researchers and trainees across the country.  March 2, 2020 (Montréal, QC) – The Stem Cell Network (SCN) announced today $6.9 million in funding for innovative stem cell and regenerative medicine research that will help advance discoveries into better health and economic growth for Canadians. The announcement …

Read more